RA Capital Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

RA Capital Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,858,260	Closed	-$233M	–	66
2020 Q1	$233M	Hold	4,858,260	–	–	7.37%	2
2019 Q4	$228M	Hold	4,858,260	–	–	6.91%	3
2019 Q3	$115M	Hold	4,858,260	–	–	6.85%	4
2019 Q2	$137M	Hold	4,858,260	–	–	7.35%	4
2019 Q1	$109M	Hold	4,858,260	–	–	4.69%	5
2018 Q4	$34M	Buy	4,858,260 +1,006,452	+26%	+$15.8M	1.98%	15
2018 Q3	$69.7M	Hold	3,851,808	–	–	3.73%	8
2018 Q2	$38.3M	Hold	3,851,808	–	–	2.49%	16
2018 Q1	$20.5M	Buy	3,851,808 +2,500,000	+185%	+$17.9M	1.57%	14
2017 Q4	$11.5M	Hold	1,351,808	–	–	0.96%	19
2017 Q3	$19.7M	Hold	1,351,808	–	–	1.78%	17
2017 Q2	$25.3M	Hold	1,351,808	–	–	2.91%	11
2017 Q1	$28.8M	Hold	1,351,808	–	–	3.53%	7
2016 Q4	$20.5M	Buy	+1,351,808	New	+$18.4M	2.91%	8

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

RA Capital Management's RARX Position: Q2 2020 in Review

RA Capital Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 4,858,260 shares — an estimated $233M sold.

RA Capital Management first reported a position in RARX in Q4 2016 and held it in 14 quarters. The position peaked at $233M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

RA Capital Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
RA Capital Management sold 4,858,260 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $233M.
RA Capital Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 14 quarters.
RA Capital Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $233M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on RA Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.